Three studies back Bionano's optical genome mapping in blood cancers

Go back to Three studies back Bionano's optical genome mapping in blood cancers
(NASDAQ: BNGO) Delayed: 1.76 -0.07 (3.83%)
Previous Close $1.83    52 Week High
Open $1.85    52 Week Low
Day High $1.87    P/E N/A 
Day Low $1.75    EPS
Volume 235,286